|
1
|
The biology of vascular endothelial growth factors.
|
Cardiovasc Res
|
2005
|
3.22
|
|
2
|
Sox18 induces development of the lymphatic vasculature in mice.
|
Nature
|
2008
|
2.91
|
|
3
|
VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites.
|
Blood
|
2006
|
2.66
|
|
4
|
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.
|
Diabetes
|
2008
|
2.41
|
|
5
|
Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
|
Circ Res
|
2008
|
2.15
|
|
6
|
Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium.
|
Arterioscler Thromb Vasc Biol
|
2008
|
1.88
|
|
7
|
PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis.
|
Blood
|
2004
|
1.30
|
|
8
|
Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2.
|
FASEB J
|
2007
|
1.24
|
|
9
|
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase.
|
J Hypertens
|
2010
|
1.12
|
|
10
|
Pulmonary vascular endothelial growth factor-C in development and lung injury in preterm infants.
|
Am J Respir Crit Care Med
|
2006
|
0.93
|
|
11
|
The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.
|
J Biol Chem
|
2013
|
0.88
|
|
12
|
Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer.
|
FASEB J
|
2011
|
0.87
|
|
13
|
Molecular pathways for lymphangiogenesis and their role in human disease.
|
Novartis Found Symp
|
2007
|
0.83
|
|
14
|
Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis.
|
Clin Exp Metastasis
|
2012
|
0.82
|